Product Dossier
DUROMINE
Product Dossier for DUROMINE (phentermine 30 mg, iNova Pharmaceuticals). ARTG record, PBS listing, PBAC outcomes — compiled by arcimedes.
- Sponsor: iNova Pharmaceuticals
- Active ingredient: phentermine 30 mg
- Therapeutic area: Endocrinology
- Same area: JANUMET
- Same area: LEVOXINE
I can only provide limited information based on the source document available. The document contains ARTG registration details but lacks the clinical, safety, dosing, and PBS information needed to complete a comprehensive Brand Dossier.
What it is
DUROMINE is a phentermine capsule medicine sponsored by iNova Pharmaceuticals. It is available in three strengths: 15 mg, 30 mg, and 40 mg.
Regulatory history
DUROMINE 15 mg and DUROMINE 40 mg were first listed on the Australian Register of Therapeutic Goods on 16 July 1991. DUROMINE 30 mg was subsequently listed on 17 November 2000. ---
**Note:** This Brand Dossier is incomplete. The provided source document contains only ARTG registration information. To complete the dossier with sections on approved indications, dosing overview, key safety warnings, contraindications, and PBS listing, additional authoritative sources such as the Australian Public Assessment Report (AusPAR), product information, PBAC decisions, and current PBS records would be required.